Among the many vexing issues faced by companies that conduct clinical trials, at least two of them — the large number of participants needed for trials and participants’ fears they will be end up ...
This piece is part of the CSIS International Security Program’s Transition46 series on Defense360. The last remaining bilateral arms control treaty between the United States and Russia—the New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results